| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Department of Medicine, University of Auckland, Auckland, New Zealand
Address all correspondence and requests for reprints to: Brandon J. Orr-Walker, Department of Medicine, University of Auckland, Private Bag, 92019, Auckland, New Zealand.
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
This important observation was subject to a number of methodological limitations however. First, the subjects were drawn from three different sources, specifically patients referred by their doctors, self-referrals, and volunteer subjects in clinical trials. It is not clear, therefore, that the cases and controls came from the same reference population, nor whether the proportion of cases and controls from each source were different. Second, although information on a large number of subjects was available for analysis, rigorous exclusion of potentially confounding conditions resulted in only 15% of those subjects with osteoporosis being included in the analysis. However 64% of those with premature hair graying were included, suggesting that the exclusion criteria affected cases and controls differently. Third, the decision to define premature hair graying as the majority of hair gray before age 40 yr was not justified and therefore might represent a post hoc analysis of the data. Supporting this possibility, Rosen et al. (1) were unable to show a significant correlation between age of hair graying and raw or age-adjusted BMD. Furthermore, defining osteopenia as a dichotomous variable is arbitrary and does not reflect the continuous relationship between BMD and fracture risk. In addition, BMD at sites other than the lumbar spine were not reported. Finally, inclusion of both male and female subjects in the same analysis may have introduced bias if there was gender disproportion in the contingency tables. The applicability of this interesting association to an otherwise healthy population at risk of osteoporosis (e.g. normal postmenopausal women) is, therefore, uncertain. We readdressed this question by examining the association between premature hair graying and BMD throughout the skeleton in 293 healthy postmenopausal women.
| Materials and Methods |
|---|
|
|
|---|
The study population comprised 404 normal postmenopausal women involved in studies of osteoporosis prevention in our department. Exclusion criteria included disorders of calcium metabolism; renal, thyroid, or hepatic dysfunction; other major systemic illness; current use of anticonvulsant or glucocorticoid drugs; past use of hormone replacement therapy for >6 months; and use of sodium fluoride, calcitonin, anabolic steroids, or bisphosphonates.
Study protocol
All women were sent a written questionnaire asking them to recall when their hair began to turn gray, and when the majority of their hair (>70%) turned gray. The responses were classified by decade of age or as not yet gray. Subjects were also asked whether they had pernicious anemia or vitiligo, conditions associated with premature hair graying. Data from subjects with either condition were excluded from the analysis. Premature hair graying was defined a priori as the majority hair graying before age 40 yr.
Measurements
BMD was assessed using a Lunar DPX-L dual-energy x-ray absorptiometer (Lunar, Madison, WI). Scans of the whole body, lumbar spine (L2-L4), and proximal femur were performed.
Statistical analysis
All analyses used the programs of SAS version 6.04 (SAS
Institute, Cary, NC). One-way ANOVA was performed to test the
hypothesis that the mean BMD at each site did not change across the
decades of hair graying. To assess whether there was a critical age of
hair graying that was associated with osteopenia, BMDs of subjects
grouped in consecutive decades were compared by Students t
test. Comparison of the BMDs of those with premature hair graying with
those of the remainder of the cohort was made using Students
t test. Comparisons of weight- and age-corrected BMDs were
made using the general linear models procedure of SAS. Because all
comparisons were made a priori, no adjustment of
(0.05)
was needed or made. All tests were two-tailed. Data are given as the
mean ± SEM unless indicated otherwise.
| Results |
|---|
|
|
|---|
Questionnaires were sent to 404 women, and completed replies received from 334 (83%). Four subjects reported pernicious anemia and 37 had vitiligo. Therefore, data from 293 subjects (73%) were available for analysis. Subjects ages ranged from 4588 yr (mean ± SD, 60 ± 5.8 yr)
BMD and decade of onset of hair graying
The mean BMD of subjects, grouped by the decade of commencement of
hair graying, is summarized in Table 1
.
ANOVA showed differences in the age- and weight-adjusted BMD at all
skeletal sites except the femoral trochanter. When data were analyzed
by comparison of successive decades, there were differences in age- and
weight-adjusted BMD between those who had onset of hair graying in
their 20s vs. those with onset in their 30s in the total
body and at the femoral trochanter, femoral neck, and Wards triangle,
with lower BMD in those with earlier graying. In addition, subjects who
reported commencement of hair graying in their 50s had lower age- and
weight-adjusted BMDs in the lumbar spine and Wards triangle than
those with commencement of hair graying in their 40s.
|
The mean BMD of subjects grouped by the decade during which the
majority of their hair became gray is summarized in Table 2
. ANOVA revealed no differences between
groups at any site except for unadjusted BMD in the total body
(P = 0.05) and a trend at the same site after
adjustment for age and weight (P = 0.07). When data
were analyzed by comparison of successive decades, age- and
weight-adjusted BMD was significantly lower in those with the majority
hair graying occurring during their 30s compared with those in whom it
occurred in their 40s atn the lumbar spine, femoral neck, femoral
trochanter, and in the total body.
|
The relationship between premature hair graying and BMD is
summarized in Table 3
. There were
significant differences between the two groups in age- and
weight-adjusted BMD in the total body and at the femoral neck and
femoral trochanter, with lower BMD in those with premature hair
graying. Nonsignificant trends towards lower BMD were noted at the
other two sites. Current smoking (n = 25) or any history of
smoking (n = 121) were unrelated to premature hair graying
(
2, P = 0.57 and P =
0.87, respectively) and had no effect on BMD.
|
|
| Discussion |
|---|
|
|
|---|
The decision to define premature hair graying as the majority of hair graying before 40 yr of age was made a priori in the present study, based on the findings of Rosen et al. (1). However, in our subject population it also appears to be the most sensitive cut off, because it marked the only significant difference of age- and weight-adjusted BMDs between decades during which the majority of hair turned gray. A similar BMD step was present in the age-of-onset of graying data (a decade earlier), representing essentially the same subjects and further justifying this cut off as the definition of premature graying.
Although significant differences in unadjusted BMD were apparent between those with the majority of hair graying in their 50s and those in their 60s, when adjusted for age and weight, significant differences only remained between those with the majority hair graying in their 30s and those in whom it developed in their 40s. The differences in unadjusted BMD between those with the majority of hair graying in their 50s vs. those in their 60s are likely to be because of the greater current age and lower weight in the latter group. BMD differences according to the reported age of onset of graying were apparent between the 20s and 30s and also the 40s and 50s. This is essentially the same group as those just discussed, though why the differences are now significant following appropriate adjustment is not clear. This may simply be a chance finding resulting from the number of comparisons we have carried out.
It is appropriate to consider the extent to which the results of this study agree with those of Rosen et al. (1). Our data are expressed in terms of the difference in bone density between women with and without premature hair graying, and also in terms of the percent of variance of BMD accounted for by premature hair graying; whereas Rosen calculated the odds ratio for a prematurely gray subject having osteopenia. Our data can also be analyzed in that way. The odds ratio of a prematurely gray woman having a bone density more than one SD below the age- and weight-adjusted mean was 1.81 (95% confidence interval, 0.565.79, P = 0.32) at the lumbar spine, 3.32 (95% confidence interval, 1.0610.43, P = 0.04) at the femoral neck, 2.64 (95% confidence interval, 0.739.56, P = 0.14) at the trochanter, 1.36 (95% confidence interval, 0.424.37, P = 0.61) at Wards triangle, and 1.48 (95% confidence interval,0.415.43, P = 0.55) in the total body. The 95% confidence intervals for all these measures overlap with that found by Rosen et al. at the lumbar spine, indicating that the two studies are broadly consistent in their findings.
It is interesting to speculate as to why hair graying may be linked to low BMD. Apart from potentially confounding associations with autoimmune conditions such as vitiligo, Addisons disease, Graves disease, premature hypogo-nadism, and Werners syndrome (each excluded from both our own and Rosens studies), premature graying has been shown to be inherited in an autosomal dominant pattern (2) and to be less frequent in racial groups with higher BMD (e.g. blacks) (3). This suggests that it may be a linked to genetic factors that influence BMD. Alternatively, the processes that lead to loss of scalp melanin production might also impact on bone turnover.
| Acknowledgments |
|---|
| Footnotes |
|---|
Received March 14, 1997.
Revised July 9, 1997.
Accepted July 21, 1997.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
D. J. Morton, D. Kritz-Silverstein, D. J. Riley, E. L. Barrett-Connor, and D. L. Wingard Premature Graying, Balding, and Low Bone Mineral Density in Older Women and Men: The Rancho Bernardo Study J Aging Health, April 1, 2007; 19(2): 275 - 285. [Abstract] [PDF] |
||||
![]() |
P. C. Arck, R. Overall, K. Spatz, C. Liezman, B. Handjiski, B. F. Klapp, M. A. Birch-Machin, and E. M. J. Peters Towards a "free radical theory of graying": melanocyte apoptosis in the aging human hair follicle is an indicator of oxidative stress induced tissue damage FASEB J, July 1, 2006; 20(9): 1567 - 1569. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |